Related Experiment Video
Updated: Jul 5, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Relationship between the lymphocyte to C‑reactive protein ratio and coronary artery disease severity
Ke Chen1,2, Yehong Liu1,2, Baida Xu1,2
1Department of Cardiology, Wuxi Clinical College of Anhui Medical University, Wuxi, Jiangsu 214044, P.R. China.
Insights
The new lymphocyte-to-C-reactive protein ratio (LCR) is a protective factor against coronary artery disease (CAD) development and severity. Higher LCR levels indicate a reduced risk of CAD, suggesting its potential as a biomarker.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Coronary atherosclerosis is a chronic inflammatory condition.
- Inflammatory markers like NLR, PLR, and SII are used to assess CAD severity.
- The lymphocyte-to-C-reactive protein ratio (LCR) is a novel inflammatory index with unclear association with CAD.
Purpose of the Study:
- To investigate the relationship between LCR and the development and severity of coronary artery disease (CAD).
- To evaluate LCR as a potential biomarker for CAD risk and progression.
Main Methods:
- A cohort of 1,107 patients undergoing coronary angiography was analyzed.
- Blood samples were assessed for routine and biochemical indices, including LCR, SII, NLR, and PLR.
- Propensity score matching (PSM) and logistic regression models were employed to analyze LCR's association with CAD and its severity.
Main Results:
- After PSM, LCR was identified as an independent protective factor against CAD development.
- In the coronary heart disease severity analysis, LCR also emerged as an independent protective factor.
- Platelet count was an independent risk factor for CAD, while NLR and PLR were risk factors for CAD severity.
Conclusions:
- The lymphocyte-to-C-reactive protein ratio (LCR) is an independent protective factor for both the development and severity of coronary artery disease.
- LCR demonstrates potential as a valuable biomarker in assessing CAD risk and progression.
Abstract:
Coronary atherosclerosis is a chronic systemic inflammatory disease. Laboratory parameters such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune inflammation index (SII) have been used to assess inflammation degree and coronary artery disease (CAD) severity. The lymphocyte-to-C-reactive protein ratio (LCR) is a new SII. However, its relationship with CAD development and severity is unclear. A total of 1,107 patients (479 in control group, 628 in CAD group) underwent coronary angiography. The routine and biochemical indices of the venous blood of patients were assessed before coronary angiography. LCR, SII, NLR and PLR were calculated and statistical analyses were performed. Propensity score matching (PSM) and a logistic regression model were used to analyze the relationship between LCR and CAD. After the PSM, 384 pairs of patients with or without CAD were successfully matched. After the median binary classification of all indicators, uni- and multivariate logistic regression analyses showed that platelet count was an independent risk factor and LCR was an independent protective factor. Using the same method, in the coronary heart disease severity group, 212 pairs were successfully matched and NLR and PLR were independent risk factors, while LCR was an independent protective factor. In conclusion, LCR is an independent protective factor against CAD development and severity.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017